Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
300
-
Total 13F shares, excl. options
-
107,728,479
-
Shares change
-
-70,714
-
Total reported value, excl. options
-
$1,962,038,029
-
Value change
-
-$1,144,218
-
Put/Call ratio
-
111%
-
Number of buys
-
153
-
Number of sells
-
-108
-
Price
-
$18.26
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2021
372 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2021.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 300 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107,728,479 shares
.
Largest 10 shareholders include ARK Investment Management LLC (18,717,144 shares), GLENVIEW CAPITAL MANAGEMENT, LLC (16,104,222 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,436,898 shares), PAULSON & CO. INC. (4,727,415 shares), NORTHERN TRUST CORP (4,559,026 shares), MACQUARIE GROUP LTD (4,301,275 shares), Parametric Portfolio Associates LLC (3,837,294 shares), Mondrian Investment Partners LTD (3,510,404 shares), RENAISSANCE TECHNOLOGIES LLC (3,434,600 shares), and BANK OF AMERICA CORP /DE/ (2,661,634 shares).
This table shows the top 300 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.